Humoral immune response after different SARS-CoV-2 vaccination regimens

BACKGROUND: The humoral immune response after primary immunisation with a SARS-CoV-2 vector vaccine (AstraZeneca AZD1222, ChAdOx1 nCoV-19, Vaxzevria) followed by an mRNA vaccine boost (Pfizer/BioNTech, BNT162b2; Moderna, m-1273) was examined and compared with the antibody response after homologous v...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Ruben, Neumann, Franziska, Grobe, Olaf, Lorentz, Thomas, Fickenscher, Helmut, Krumbholz, Andi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776512/
https://www.ncbi.nlm.nih.gov/pubmed/35057798
http://dx.doi.org/10.1186/s12916-021-02231-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776512/
https://www.ncbi.nlm.nih.gov/pubmed/35057798
http://dx.doi.org/10.1186/s12916-021-02231-x

Ejemplares similares